GlassScriptPhysician profile
Andrew P Milner
NPI 1083697973
$1,772.70
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2020: $1,198 · 2021: $153 · 2022: $138 · 2023: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $166.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,143.12 | 2020 | |
| Horizon Therapeutics Plc | $121.27 | 2019-2022 | |
| Abbott Laboratories | $82.33 | 2023 | Proclaim |
| Kowa Pharmaceuticals America, INC. | $62.30 | 2022-2023 | Seglentis |
| Grt US Holding, INC. | $51.08 | 2020-2021 | |
| Bioventus LLC | $45.96 | 2021-2022 | |
| Convatec INC. | $30.19 | 2023 | |
| Sebela Pharmaceuticals INC. | $27.29 | 2020-2021 | |
| Southtech Orthopedics | $23.06 | 2021 | |
| Smith+Nephew, INC. | $22.36 | 2019 | |
| Averitas Pharma INC. | $21.98 | 2023 | Qutenza |
| Arthrosurface Incorporated | $20.97 | 2019 | |
| Cardiovascular Systems INC. | $18.57 | 2021 | |
| Nevro Corp. | $18.06 | 2023 | Senza |
| Stryker Corporation | $17.32 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $15.40 | 2019 | |
| Paratek Pharmaceuticals, INC. | $13.65 | 2021 | |
| Nabriva Therapeutics, Plc | $13.21 | 2021 | |
| Zimvie INC. | $12.30 | 2022 | |
| Merck Sharp & Dohme LLC | $12.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Milner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.